http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_17888cb19c3beea5202ba215795aa20d
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Gilbert |
| name | Jill Gilbert |
| given-name | Jill |
| organization-name | Vanderbilt University School of Medicine, Nashville, TN, USA. jill.gilbert@vanderbilt.edu Athanassios Argiris, The University of Texas Health Science Center at San Antonio, San Antonio, TX; Musie Ghebremichael, Ragon Institute of Harvard, Massachusetts Institute of Technology, Massachusetts General Hospital, and Harvard Medical School; Ju-Whei Lee, Dana-Farber Cancer Institute, Boston, MA; Jill Gilbert, Vanderbilt University, Nashville, TN; Kamakshi Sachidanandam, Jill M. Kolesar, University of Wisconsin, Madison, WI; Barbara Burtness, Fox Chase Cancer Center, Philadelphia, PA; Arlene A.... From the Vanderbilt University School of Medicine, Nashville, TN; University of California Davis School of Medicine, Sacramento, CA; Vanderbilt University School of Medicine, Nashville, TN. 1Division of Oncology and Hematology, Stanley S. Scott Cancer Center, Louisiana State University, New Orleans, Louisiana, and Divisions of Authors' Affiliations: 1Premiere Oncology, Santa Monica, California; 2Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee; 3Amgen Inc., Thousand Oaks, California; and 4Institute for Drug Development, Cancer Therapy and Research Center, The University of Texas Health Science Center at San Antonio, San Antonio, Texas Authors' Affiliations: 1Division of Hematology/Oncology, Department of Medicine, 2Department of Cancer Biology, 3Department of Biochemistry, Vanderbilt-Ingram Comprehensive Cancer Center, Vanderbilt University School of Medicine, Nashville, Tenessee; 4Biodesix, Steamboat Springs, Colorado; 5Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania; 6University of Pittsburgh, Pittsburgh, Pennsylvania; 7Johns Hopkins University, Baltimore, Maryland; and 8Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, Illinois Leora Horn, Elizabeth Koehler, and Jill Gilbert, Vanderbilt Ingram Cancer Center, Nashville, TN; and David H. Johnson, University of Texas Southwestern, Dallas, TX. Department of Medicine, Vanderbilt University, Nashville, TN, USA Vanderbilt University, Nashville, TN 1Tumor Immunology Program, Stanley S. Scott Cancer Center Authors' Affiliations: 1Chemical Therapeutics Program, 2Cancer Biology, and 3Hematologic Malignancies, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Johns Hopkins University, Baltimore, Maryland; 4Department of Medical Oncology, The Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee; 5St. Jude Children's Hospital, Memphis, Tennessee; and 6Cancer Therapy and Evaluation Program, National Cancer Institute, NIH, Bethesda, Maryland From the Divisions of Medical Oncology, Experimental Therapeutics, and Hematologic Malignancy, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 1Vanderbilt Ingram Cancer Center, Nashville, Tennessee. Division of Hematology and Oncology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA. jill.gilbert@vanderbilt.edu Joshua Bauml, University of Pennsylvania, Philadelphia, PA; Tanguy Y. Seiwert, University of Chicago, Chicago, IL; David G. Pfister, Memorial Sloan Kettering Cancer Center, New York, NY; Francis Worden, University of Michigan Comprehensive Cancer Center, Ann Arbor; Ammar Sukari, Karmanos Cancer Institute, Wayne State University, Detroit, MI; Stephen V. Liu, Georgetown University Hospital, Washington, DC; Jill Gilbert, Vanderbilt University School of Medicine, Nashville, TN; Nabil F. Saba, Winship Cancer... Authors' Affiliations: 1University of North Carolina Lineberger Comprehensive Cancer Center, School of Medicine; 2University of North Carolina, Department of Pathology & Laboratory Medicine, Chapel Hill, North Carolina; 3The University of Chicago Medical Center, Chicago, Illinois; 4Fox Chase Cancer Center, Philadelphia, Pennsylvania; 5Princess Margaret Hospital, Toronto, Ontario, Canada; 6Vanderbilt University, Nashville, Tennessee; 7H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida; and 8Johns Hopkins University School of Medicine, Baltimore, Maryland From the *Department of Radiology and Radiological Sciences, Vanderbilt University Medical Center; †Tennessee Valley VA Healthcare System; ‡Vanderbilt-Ingram Cancer Center; §Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center; ∥Vanderbilt University Institute of Imaging Sciences; and ¶Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN. Department of Hematology and Oncology, Henry-Joyce Cancer Clinic, Nashville, Tennessee 4Vanderbilt Ingram Cancer Center, Nashville, Tennessee. Vanderbilt University Medical Center, Nashville, TN, USA Department of Medicine, Oncology Division Vanderbilt University Medical Center Nashville Tennessee USA Vanderbilt University School of Medicine, Nashville, TN Division of Hematology-Oncology, Department of Medicine, Vanderbilt University Medical Center, Vanderbilt Ingram Cancer Center, Nashville, TN Vanderbilt University, Nashville, TN, USA Shanthi Marur and William H. Westra, Johns Hopkins University, Baltimore, MD; Shuli Li, Dana Farber Cancer Institute, Boston, MA; Anthony J. Cmelak, Jill Gilbert, and Barbara A. Murphy, Vanderbilt University, Nashville, TN; Maura L. Gillison and Weiqiang J. Zhao, Ohio State University, Columbus, OH; Robert L. Ferris and Julie E. Bauman, University of Pittsburgh, Pittsburgh, PA; Lynne I. Wagner, Wake Forest School of Medicine, Winston-Salem, NC; David R. Trevarthen, Colorado Cancer Research Program,... Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. Vanderbilt‐Ingram Cancer Center Nashville Tennessee Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA |
Incoming Links
Total number of triples: 107.